C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/00 (2006.01) C07K 7/08 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2403803
The invention concerns a molecule of pharmaceutical interest, preferably a major histocompatibility complex (MHC) ligand, comprising a glutamic acid or a glutamine at its N-terminal, in the form of a physiologically acceptable addition salt, and a vaccine comprising such a ligand.
La présente invention a pour objet une molécule d'intérêt pharmaceutique, de préférence un ligand du Complexe Majeur d'Histocompatibilité (CMH), comportant un acide glutamique ou une glutamine à son extrémité N-terminale, qui se présente sous forme de sel d'addition d'acide fort physiologiquement acceptable, ainsi qu'un vaccin comprenant un tel ligand.
Beck Alain
Corvaia Nathalie
Goetsch Liliane
Klinguer-Hamour Christine
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Pierre Fabre Medicament
LandOfFree
Molecule of pharmaceutical interest comprising at its... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Molecule of pharmaceutical interest comprising at its..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Molecule of pharmaceutical interest comprising at its... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1997216